Canaccord lowered the firm’s price target on Aspen Aerogels (ASPN) to $28 from $33 and keeps a Buy rating on the shares. The firm said its solod execution continued as they showed great margin progression, increased their guidance for the year, announced a new OEM win (Mercedes-Benz), and articulated a plan whereby the Georgia plant would quickly be margin accretive.